These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7526791)

  • 21. Human papillomavirus detection in genital lesions by in situ hybridization and ultrastructural observations.
    Oliveira LH; Frugulhetti IC; Passos MR; Cavalcanti SM; Fonseca ME
    Mem Inst Oswaldo Cruz; 1994; 89(2):195-202. PubMed ID: 7885244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus infection and genital warts: update on epidemiology and treatment.
    Stone KM
    Clin Infect Dis; 1995 Apr; 20 Suppl 1():S91-7. PubMed ID: 7540876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon treatment of anogenital human papillomavirus-related diseases.
    Trofatter KF
    Dermatol Clin; 1991 Apr; 9(2):343-52. PubMed ID: 1711942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Traditional therapies for the treatment of condylomata acuminata (genital warts).
    Jablonska S
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S2-4. PubMed ID: 9842092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic approaches to papillomavirus infections.
    Baker GE; Tyring SK
    Dermatol Clin; 1997 Apr; 15(2):331-40. PubMed ID: 9098642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imiquimod: a cytokine inducer.
    Dahl MV
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
    [No Abstract]   [Full Text] [Related]  

  • 28. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata.
    Gammon DC; Reed KA; Patel M; Balaji KC
    Am J Health Syst Pharm; 2008 Oct; 65(19):1830-3. PubMed ID: 18796424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and treatment of human genital papillomavirus infections: a review.
    Reichman RC; Strike DG
    Antiviral Res; 1989 Apr; 11(3):109-18. PubMed ID: 2544136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus DNA detection-guided ALA-photodynamic therapy for anogenital condyloma acuminata: A report of two cases.
    Wang J; Li S; Li Z; Li J; Peng X; Li S; Jiang L; Liu H; Zeng K
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():460-462. PubMed ID: 30738225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podophyllin and pregnancy.
    Bargman H
    Int J Dermatol; 1993 Sep; 32(9):691. PubMed ID: 8407103
    [No Abstract]   [Full Text] [Related]  

  • 33. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of compound periploca liquid in treating condyloma acuminatum and its effect on human papilloma virus DNA expression in vitro].
    Cui BN; Xu X; Zhao YS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 May; 25(5):392-6. PubMed ID: 15957827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of interleukin 2 and interferon alpha in the management of cervical condylomatosis].
    Zarcone R; Bellini P; Cardone G; Barletta E; Vicinanza G
    Minerva Ginecol; 1996 Mar; 48(3):111-3. PubMed ID: 8684685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis.
    Westfechtel L; Werner RN; Dressler C; Gaskins M; Nast A
    Sex Transm Infect; 2018 Feb; 94(1):21-29. PubMed ID: 28819018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon response depends on viral transcription in human papillomavirus-containing lesions.
    Arany I; Goel A; Tyring SK
    Anticancer Res; 1995; 15(6B):2865-9. PubMed ID: 8669880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interferons. Mechanisms of action and clinical applications.
    Baron S; Tyring SK; Fleischmann WR; Coppenhaver DH; Niesel DW; Klimpel GR; Stanton GJ; Hughes TK
    JAMA; 1991 Sep; 266(10):1375-83. PubMed ID: 1715409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon resistance is independent from copy numbers in benign HPV-induced lesions.
    Arany I; Nagamani K; Tyring SK
    Anticancer Res; 1995; 15(3):1003-6. PubMed ID: 7645918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranpirnase eradicates human papillomavirus in cultured cells and heals anogenital warts in a Phase I study.
    Squiquera L; Taxman DJ; Brendle SA; Torres R; Sulley J; Hodge T; Christensen N; Sidransky D
    Antivir Ther; 2017; 22(3):247-255. PubMed ID: 28121292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.